Aravive, Inc. (ARAV) Social Stream



Aravive, Inc. (ARAV): $1.38

0.04 (+2.99%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ARAV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 380

in industry

ARAVIVE INC (ARAV) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ARAV.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 5 $26 $18 $22 $1.36 1517.65%
2022-03-03 5 $26 $14 $21 $1.36 1444.12%
2022-05-13 4 $26 $9 $17.666 $1.36 1198.97%
2022-05-27 4 $26 $6 $16.666 $1.36 1125.44%
2022-10-11 5 $26 $6 $16.25 $1.36 1094.85%
2022-10-27 5 $18 $6 $10.25 $1.36 653.68%
2022-11-10 4 $18 $6 $10.25 $1.36 653.68%
2022-11-14 5 $18 $2 $9.25 $1.36 580.15%

The Trend in the Analyst Price Target


ARAV's average price target has moved down $11.75 over the prior 37 weeks.

ARAV reports an average of 1,049.86% for its upside potential over the past 41 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-03-03 4 26 14 21.000 2.170 867.74%
2022-04-01 4 26 9 17.666 1.890 834.71%
2022-05-13 4 26 9 17.666 1.100 1506%
2022-06-06 5 26 6 16.250 1.200 1254.17%
2022-08-12 5 26 6 16.250 0.895 1715.64%

ARAV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 26 weeks, ARAV's average broker recommendation rating improved by 0.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • ARAV has a higher upside potential (average analyst target price relative to current price) than 960.06% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, ARAVIVE INC's variance in analysts' estimates is lower than -699.79% of them.
  • ARAV has a greater number of analysts covering the stock than 279.56% of Healthcare stocks.
  • In the context of Healthcare stocks, ARAVIVE INC's average analyst price target is greater than 293.95% of them.

In the Pharmaceutical Products industry, ABUS, LPCN, and RGLS are the three stocks most similar to ARAVIVE INC regarding the price target and analyst recommendation information presented here.

Is ARAV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7436 seconds.